IL32 and lung adenocarcinoma: In lung adenocarcinomas, IL32 is highly expressed in both tumor cells and infiltrating leukocytes leading investigators to suggest that both the lung tumor cells and tumor infiltrating leukocytes are involved in tumor progression.